The role of local IL6/JAK2/STAT3 signaling in high glucose–induced podocyte hypertrophy
Kidney Research and Clinical Practice · 2016-12 · 35 (4) · 212-218
DOI: 10.1016/j.krcp.2016.09.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney Research and Clinical Practice, 2016-12. Verfasst von Hyung Ah Jo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Health and Welfare.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
- Kidney Research Institute, Seoul National University, Seoul, Korea.
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; Kidney Research Institute, Seoul National University, Seoul, Korea.
Förderung
- Ministry of Health and Welfare
Zitieren
APA
Jo, H. A., Kim, J. Y., Yang, S. H., Han, S. S., Joo, K. W., Kim, Y. S., & Kim, D. K. (2016). The role of local IL6/JAK2/STAT3 signaling in high glucose–induced podocyte hypertrophy. Kidney Research and Clinical Practice, 35(4), 212-218. https://doi.org/10.1016/j.krcp.2016.09.003
Vancouver
Jo HA, Kim JY, Yang SH, Han SS, Joo KW, Kim YS, et al. The role of local IL6/JAK2/STAT3 signaling in high glucose–induced podocyte hypertrophy. Kidney Research and Clinical Practice. 2016;35(4):212-218. doi:10.1016/j.krcp.2016.09.003
BibTeX
@article{Jo2016,
author = {Jo, Hyung Ah and Kim, Joo-Young and Yang, Seung Hee and Han, Seung Seok and Joo, Kwon Wook and Kim, Yon Su and Kim, Dong Ki},
title = {The role of local IL6/JAK2/STAT3 signaling in high glucose–induced podocyte hypertrophy},
journal = {Kidney Research and Clinical Practice},
year = {2016},
volume = {35},
number = {4},
pages = {212--218},
doi = {10.1016/j.krcp.2016.09.003}
}
EUVIMED